Cargando…
This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mosby
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695307/ https://www.ncbi.nlm.nih.gov/pubmed/34953959 http://dx.doi.org/10.1016/j.jaad.2021.12.031 |
| _version_ | 1784619548099477504 |
|---|---|
| author | Sloan, Brett |
| author_facet | Sloan, Brett |
| author_sort | Sloan, Brett |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8695307 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Mosby |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86953072021-12-23 This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2 Sloan, Brett J Am Acad Dermatol This month in JAAD Case Reports Mosby 2022-03 2021-12-23 /pmc/articles/PMC8695307/ /pubmed/34953959 http://dx.doi.org/10.1016/j.jaad.2021.12.031 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | This month in JAAD Case Reports Sloan, Brett This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2 |
| title | This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2 |
| title_full | This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2 |
| title_fullStr | This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2 |
| title_full_unstemmed | This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2 |
| title_short | This Month in JAAD Case Reports: March 2022. Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2 |
| title_sort | this month in jaad case reports: march 2022. reactive infectious mucocutaneous eruption secondary to sars-cov-2 |
| topic | This month in JAAD Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695307/ https://www.ncbi.nlm.nih.gov/pubmed/34953959 http://dx.doi.org/10.1016/j.jaad.2021.12.031 |
| work_keys_str_mv | AT sloanbrett thismonthinjaadcasereportsmarch2022reactiveinfectiousmucocutaneouseruptionsecondarytosarscov2 |